MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients

CompletedOBSERVATIONAL
Enrollment

215

Participants

Timeline

Start Date

November 12, 2020

Primary Completion Date

September 22, 2021

Study Completion Date

September 30, 2022

Conditions
Covid19Coronavirus InfectionSARS-CoV Infection
Interventions
DIAGNOSTIC_TEST

MRI (heart, brain, lungs, liver)

MRI (heart, brain, lungs, liver)

DIAGNOSTIC_TEST

Bloodwork

Serum biomarkers to assess systemic inflammation, renal function, cardiac injury, liver injury and steatosis, ACE-2 related peptides, cytokines, Activin A and autoantibodies to cardiac antigens, humoral cell RNA

OTHER

Cognitive testing

NIH toolbox Cognitive Measures

OTHER

Olfaction testing

Brief Smell Identification Test (BSIT)

DIAGNOSTIC_TEST

Spirometry

Spirometry to evaluate forced expiratory volume in 1 second and forced vital capacity

OTHER

Walk Test

Walk test to record overall distance walked in 6 minutes and time taken to walk the first 25 feet

Trial Locations (2)

Unknown

University of Calgary, Calgary

University of Alberta, Edmonton

All Listed Sponsors
collaborator

Canadian VIGOUR Centre

OTHER

lead

University of Alberta

OTHER

NCT04525404 - MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients | Biotech Hunter | Biotech Hunter